All FDA-approved EMA-approved PMDA-approved
Target Card Uniprot Example: P23975

enprofylline 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definition	Drug id	CAS RN
N-methylated xanthine derivatives	1015	41078-02-8

Description:

Molecule	Description
Molfile Inchi Smiles Synonyms: enprofylline 3-Propylxanthine	Molecular weight: 194.19 Formula: C8H10N4O2 CLOGP: 0.40 LIPINSKI: 0 HAC: 6 HDO: 2 TPSA: 78.09 ALOGS: -1.53 ROTB: 2

Drug dosage:

None

ADMET properties:

Property	Value	Reference
BDDCS (Biopharmaceutical Drug Disposition Classification System)	3	Hosey CM, Chan R, Benet LZ
BA (Bioavailability)	88 %
Vd (Volume of distribution)	0.63 L/kg	Lombardo F, Berellini G, Obach RS
CL (Clearance)	4 mL/min/kg	Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma)	0.55 %	Lombardo F, Berellini G, Obach RS
t_half (Half-life)	1.80 hours	Lombardo F, Berellini G, Obach RS
S (Water solubility)	5.68 mg/mL	Bocci G, Oprea TI, Benet LZ

Predicted pharmacokinetic/toxicological properties (PK-AZ):

Property	Description	Value	Unit	Confidence	Similarity
kinase-safety-class	ACVR2A,ACVR2B,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,CHEK1,CSF1R,DDR1,DYRK1B,EIF2AK3,ERBB2,FLT3,GRK2,GRK3,GSK3B,IGF1R,ITK,JAK1,JAK2,MAP3K21,MAP3K7,MAP4K1,MAPK7,MAPK9,MARK4,MET,MTOR,NTRK2,PDK1,PDK2,PDPK1,PIK3CB,PIK3CD,PIM2,PLK1,PLK2,PLK4,PRKCD,PRKDC,PTK2,SIK2,SIK3,STK33,SYK,TEK,TTK,ULK1,ULK2	55
kinase-selectivity-class	ACVR2B,AXL,BRAF,CAMK2D,CDK9,GRK2,GRK3,MAPK7,PDK1,STK33	10
pfas-class	PFAS structural alert (1 = True, 0 = False)	0

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
MeSH PA	D001993	Bronchodilator Agents
MeSH PA	D018373	Peripheral Nervous System Agents
MeSH PA	D018377	Neurotransmitter Agents
MeSH PA	D018927	Anti-Asthmatic Agents
MeSH PA	D019141	Respiratory System Agents
MeSH PA	D058914	Purinergic Antagonists
MeSH PA	D058915	Purinergic P1 Receptor Antagonists
MeSH PA	D058917	Adenosine A2 Receptor Antagonists
CHEBI has role	CHEBI:35475	non-steroidal anti-inflammatory drug
CHEBI has role	CHEBI:35523	bronchodilator agent
CHEBI has role	CHEBI:38070	anti-arrhythmia drug
CHEBI has role	CHEBI:49167	anti-asthmatic drug

Drug Use | Suggest Off label Use Form| |View source of the data|

None

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation level	Dissociation constant	Type (acidic/basic)
pKa1	7.61	acidic
pKa2	8.27	acidic
pKa3	2.65	Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Mechanism action	Bioact source	MoA source
Adenosine receptor A2a	GPCR	P29274	AA2AR_HUMAN		Ki	4.49		CHEMBL
Adenosine receptor A1	GPCR	P30542	AA1R_HUMAN		Ki	4.38		CHEMBL
Adenosine receptor A2b	GPCR	P29275	AA2BR_HUMAN		Ki	5.33		CHEMBL
Adenosine receptor A3	GPCR	P0DMS8	AA3R_HUMAN		Ki	4.03		CHEMBL
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Enzyme	Q07343	PDE4B_HUMAN					WOMBAT-PK
Adenosine receptor A1	GPCR		AA1R_RAT		Ki	4.49		CHEMBL
Adenosine receptor A2a	GPCR		AA2AR_RAT		Ki	4.49		CHEMBL
Adenosine receptor A3	GPCR		AA3R_RAT		Ki	4.19		CHEMBL
Adenosine receptor A1	GPCR		AA1R_CAVPO		Ki	4.22		CHEMBL
Adenosine A2a receptor	GPCR		AA2AR_CAVPO		Ki	4.04		CHEMBL

External reference:

ID	Source
D04006	KEGG_DRUG
C0059372	UMLSCUI
CHEBI:126237	CHEBI
CHEMBL279898	ChEMBL_ID
DB00824	DRUGBANK_ID
1676	PUBCHEM_CID
C034347	MESH_SUPPLEMENTAL_RECORD_UI
4878	INN_ID
DT7DT5E518	UNII
A1BD3	PDB_CHEM_ID
DT7DT5E518	INXIGHT DRUGS

Pharmaceutical products:

None